Quotient and Transmedic have signed a distribution agreement, which will enable Transmedic to distribute Alba by Quotient® and MosaiQ™ in five countries in Southeast Asia.
This significant partnership reaffirms Quotient’s commitment to grow and expand its geographical presence. It will enable both parties to introduce new quality services to the healthcare industry in Southeast Asia and enhance patient care.
With a history spanning over four decades, Transmedic is a leader in medical technology. Headquartered in Singapore, the company operates in Southeast Asia. It is active in the distribution of medical devices and specialized drugs, education, and post-sales support.
The distribution agreement takes effect immediately and will cover the following five countries in Southeast Asia:
Transmedic will be able to distribute the Alba by Quotient portfolio, our range of high-quality reagents, along with the MosaiQ solution, which is currently under development and aims to facilitate fast and accurate test results in the autoimmune diseases and allergy fields.
“We are thrilled to collaborate with such a strong partner and to be able to expand our operations in Southeast Asia,” said Khaled Hamed, Quotient’s Head of APAC.
To find out more about Transmedic, please visit their website: www.transmedicgroup.com